Lite Strategy, Inc. (LITS)
0.9804
-0.02
(-1.96%)
USD |
NASDAQ |
Aug 28, 16:00
1.01
+0.03
(+3.02%)
After-Hours: 20:00
Lite Strategy Total Return Price : 0.9804 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 0.9804 |
| August 27, 2026 | 1.00 |
| August 26, 2026 | 0.9931 |
| August 25, 2026 | 1.05 |
| August 24, 2026 | 1.03 |
| August 21, 2026 | 0.9897 |
| August 20, 2026 | 0.9434 |
| August 19, 2026 | 0.94 |
| August 18, 2026 | 0.882 |
| August 17, 2026 | 0.8801 |
| August 14, 2026 | 0.8865 |
| August 13, 2026 | 0.8955 |
| August 12, 2026 | 0.9215 |
| August 11, 2026 | 0.9012 |
| August 10, 2026 | 0.8701 |
| August 07, 2026 | 0.9075 |
| August 06, 2026 | 0.929 |
| August 05, 2026 | 0.9554 |
| August 04, 2026 | 0.9443 |
| August 03, 2026 | 0.9812 |
| July 31, 2026 | 0.9635 |
| July 30, 2026 | 0.9872 |
| July 29, 2026 | 0.9513 |
| July 28, 2026 | 0.97 |
| July 27, 2026 | 0.9765 |
| Date | Value |
|---|---|
| July 24, 2026 | 0.9884 |
| July 23, 2026 | 0.9918 |
| July 22, 2026 | 1.03 |
| July 21, 2026 | 1.00 |
| July 20, 2026 | 1.03 |
| July 17, 2026 | 0.9866 |
| July 16, 2026 | 0.9702 |
| July 15, 2026 | 0.9891 |
| July 14, 2026 | 0.9969 |
| July 13, 2026 | 0.9458 |
| July 10, 2026 | 1.01 |
| July 09, 2026 | 0.993 |
| July 08, 2026 | 0.9769 |
| July 07, 2026 | 0.9712 |
| July 06, 2026 | 0.9757 |
| July 02, 2026 | 0.9504 |
| July 01, 2026 | 0.9698 |
| June 30, 2026 | 0.9224 |
| June 29, 2026 | 0.9094 |
| June 26, 2026 | 0.898 |
| June 25, 2026 | 0.8172 |
| June 24, 2026 | 0.873 |
| June 23, 2026 | 0.89 |
| June 22, 2026 | 0.8937 |
| June 18, 2026 | 0.8278 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 13.21 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.26 |